Predictive Value of CD44 for Prognosis in Patients with Breast Cancer.
Chetana Prakash DeshmukhZohreh SanaatAli Reza NikanfarMohammad Hossein SomiAshraf FakhrjouPublished in: Asian Pacific journal of cancer prevention : APJCP (2020)
The results from this study suggest that CD44 is clinically associated with stage of breast cancers. From the survival analysis, there was no statistical difference in overall survival and disease free survival with respect to CD44 expression. Further studies larger sample sizes are recommended for further investigation.